NCT05026983 2026-04-16Binimetinib and Encorafenib for the Treatment of Metastatic Melanoma and Central Nervous System MetastasesM.D. Anderson Cancer CenterPhase 2 Recruiting35 enrolled
NCT04061980 2026-04-13Encorafenib and Binimetinib With or Without Nivolumab in Treating Patients With Metastatic Radioiodine Refractory BRAF V600 Mutant Thyroid CancerProvidence Health & ServicesPhase 2 Active not recruiting24 enrolled